Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ataxia–telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential for the development of additional uncommon tumors in an already rare patient population. We report the first case, to our knowledge, of an incidental retroperitoneal tumor in a 26-year-old woman undergoing evaluation for hepatic dysfunction. The mass was suspicious for retroperitoneal sarcoma, but proved to be an extramedullary hematopoietic pseudotumor after extensive pathologic evaluation. The changing landscape of neoplasms associated with ataxia–telangiectasia is discussed with emphasis on previously underreported benign and malignant tumors.

Cite

CITATION STYLE

APA

Judge, S. J., Plescia, T. A., Bateni, C. P., Darrow, M. A., Evans, C. P., & Canter, R. J. (2018). Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia. Rare Tumors, 10. https://doi.org/10.1177/2036361318789724

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free